# Novartis

- Headquarters: Switzerland
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Sites

| Place | Latest | Largest value | Types |
| --- | --- | --- | --- |
| Stein, Switzerland | 2018-08-28 | $92.0M | new_facility |

## Customers, suppliers and deals

- [BioNTech](https://endata.com/companies/27269.md): acquired by, 1×, latest 2020-09-01
- [SomaLogic](https://endata.com/companies/42821.md): supplier, 1×, latest 2019-10-21
- [Recordati](https://endata.com/companies/40611.md): acquired by, 1×, latest 2019-07-12
- [Endocyte](https://endata.com/companies/32999.md): acquired, 1×, latest 2018-12-20

## Announcements (8)

- 2020-09-01: [BioNTech to acquire Novartis GMP manufacturing site in Marburg, Germany](https://endata.com/announcements/51297-biontech-to-acquire-novartis-gmp-manufacturing-site-in-marburg-germany) (Acquisition · Marburg, Germany, Germany · 300 jobs)
- 2019-11-18: [Biofourmis acquires Biovotion and inks commercialization deal with Novartis](https://endata.com/announcements/43968-biofourmis-acquires-biovotion-and-inks-commercialization-deal-with-novartis) (Acquisition · Zürich, Switzerland, Switzerland)
- 2019-10-21: [SomaLogic and Novartis sign ten-year proteomics agreement](https://endata.com/announcements/43246-somalogic-and-novartis-sign-ten-year-proteomics-agreement) (Contract)
- 2019-07-12: [Recordati to acquire worldwide rights to Signifor and Osilodrostat from Novartis](https://endata.com/announcements/40761-recordati-to-acquire-worldwide-rights-to-signifor-and-osilodrostat-from-novartis) (Acquisition · $390.0M)
- 2019-02-19: [AveXis expands gene therapy manufacturing facility in North Carolina with additional $60M investment](https://endata.com/announcements/37057-avexis-expands-gene-therapy-manufacturing-facility-in-north-carolina-with) (Expansion · Durham, North Carolina, United States · $60.0M · 200 jobs · starts operating Q3 2020)
- 2018-12-20: [Novartis completes $2B acquisition of Endocyte](https://endata.com/announcements/35770-novartis-completes-2b-acquisition-of-endocyte) (Acquisition · United States · $2.00B)
- 2018-08-28: [Novartis to build $92M cell and gene therapy plant in Stein, Switzerland](https://endata.com/announcements/33006-novartis-to-build-92m-cell-and-gene-therapy-plant-in-stein-switzerland) (New facility · Stein, Switzerland · $92.0M · 450 jobs)
- 2018-05-23: [AveXis to build $55M gene therapy plant in Durham, North Carolina](https://endata.com/announcements/30847-avexis-to-build-55m-gene-therapy-plant-in-durham-north-carolina) (New facility · Durham, North Carolina, United States · $55.0M · 200 jobs)

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.